@article{d1dbf3880d92456d87c527c6eac5d4a2,
title = "Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study",
author = "Reville, {Patrick K.} and Kantarjian, {Hagop M.} and Farhad Ravandi and Elias Jabbour and DiNardo, {Courtney D.} and Naval Daver and Naveen Pemmaraju and Maro Ohanian and Yesid Alvarado and Lianchun Xiao and Gheath Alatrash and Sanam Loghavi and Rausch, {Caitlin R.} and Gautam Borthakur and Marina Konopleva and Jorge Cortes and Kadia, {Tapan M.}",
note = "Funding Information: The authors thank the patients and their families who participated in this clinical trial. We also thank the research coordinators, research nurses, advance practice providers, and other staff for their support of this clinical trial. This work was supported by Bristol-Myers Squibb, the MD Anderson Cancer Center Leukemia Support Grant CA016672, the MD Anderson Cancer Center Leukemia SPORE CA100632, and the MD Anderson Moon Shots Program. PKR is supported by a T32 grant from the NIH (T32CA009666). This work was previously presented at EHA 2017 and ASCO 2018.",
year = "2021",
month = mar,
doi = "10.1038/s41408-021-00453-z",
language = "English (US)",
volume = "11",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "3",
}